Patents Assigned to Al-Urdonia Lemudaddat Al-Ajsam Co.
  • Patent number: 10278404
    Abstract: The present invention relates to a novel composition with milk of immunized camelid, particularly, (Camelus dromedarius) as the main component (i.e. active ingredient) and a method for the treatment or prevention of gastrointestinal infections, particularly, infections caused by Escherichia coli (E. coli), Helicobacter Pylori (H. pylori), Campylobacter jejuni (C. jejuni), Salmonella enterica, Shigella dysenteriae, Clostridium perfringens, or Yersinia enterocolitica. Said composition is prepared in the form of pharmaceutical, nutraceutical, or health food preparations. The present invention also discloses a process of preparing said composition.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 7, 2019
    Assignee: AL-URDONIA LEMUDADDAT AL-AJSAM CO
    Inventors: Khaled Mahmood Al-Qaoud, Penelope Agmad Shihab, Luay Fawzi Abu-Oatousch, Christopher R. Lowe
  • Publication number: 20180344773
    Abstract: The present invention relates to a novel pharmaceutical composition with milk of immunized camelid, particularly Camelus dromedaries as the main component (i.e. active ingredient) and a method for the treatment or prevention of skin or mucus membrane infections, particularly Acne vulgaris. The present invention also discloses a process of preparing said composition.
    Type: Application
    Filed: May 22, 2018
    Publication date: December 6, 2018
    Applicant: Al-Urdonia Lemudaddat Al-Ajsam Co.
    Inventors: Khaled Mahmood Al-Qaoud, Penelope Ahmad Shihab, Luay Fawzi Abu-Qatouseh, Christopher R. Lowe
  • Patent number: 8877980
    Abstract: The present invention relates to a specific phenylboronic acid compound having anti-cancer, anti-inflammatory, and anti-microbial activity, in addition to a pharmaceutical composition comprising the same. The present invention also discloses a process for preparing said compound.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: November 4, 2014
    Assignee: Al-Urdonia Lemudaddat Al-Ajsam Co.
    Inventors: Khaled Mahmood Al-Qaoud, Penelope Ahmad Shihab, Luay Fawzi Abu-Qatouseh, Christopher R. Lowe, Abdel Monem Mohammad Rawashdeh, Yusuf Abdalsalam Alkhayyat, Samer Sami Ratrout, Saleem Muneer Naser
  • Publication number: 20140072649
    Abstract: The present invention relates to a novel composition with milk of immunized camelid, particularly, (Camelus dromedarius) as the main component (i.e. active ingredient) and a method for the treatment or prevention of gastrointestinal infections, particularly, infections caused by Escherichia coli (E. coli), Helicobacter Pylori (H. pylori), Campylobacter jejuni (C. jejuni), Salmonella enterica, Shigella dysenteriae, Clostridium perfringens, or Yersinia enterocolitica. Said composition is prepared in the form of pharmaceutical, nutraceutical, or health food preparations. The present invention also discloses a process of preparing said composition.
    Type: Application
    Filed: September 11, 2012
    Publication date: March 13, 2014
    Applicant: Al-Urdonia Lemudaddat Al-Ajsam Co.
    Inventors: Khaled Mahmood Al-Qaoud, Penelope Ahmad Shihab, Luay Fawzi Abu-Qatouseh, Christopher R. Lowe